Cocrystal Pharma, a Seattle-area company co-founded by a Nobel Prize winner and backed by biotech veterans, is taking aim at high-profile viruses. The publicly traded company has the green light… Read More
As a bear market takes a bite out of biotech stock values that had soared during the pandemic, some companies are retrenching. Adaptive Biotechnologies had recently doubled its headcount as… Read More